Stock Market Today: Nifty Pharma Index saw steep cuts of more than 1.8% in the morning trades on Tuesday amidst Trump Tariff concerns: Aurobindo ... to boost domestic drug manufacturing as ...

Aurobindo Pharma Limited (APL), one of the worlds top ... Cumulatively, the Company has filed a total of 337 DMFs (Drug Master Files), of which 110 are with US FDA, and 133 in Europe including ...

Aurobindo Pharma were down by around 2 per cent today. According to reports, the executive order signed by Trump directs the US Food and Drug Administration (USFDA) to streamline reviews and work ...

About10 per cent of the Sun Pharma's US specialty revenues is formulated in the US, as per some estimates. Aurobindo Pharma and Gland Pharma have fallen 6-10 per cent each in the past one week and ...

Aurobindo Pharma share price has gained 4% in one month, but the stock has dropped nearly 10% on a year-to-date (YTD) basis. In the past one year, Aurobindo Pharma shares gained 5%, while the ...

India supplies over 45% of the generics and 15% of biosimilars used in the U.S., with major companies like Dr. Reddy’s, Aurobindo Pharma ... and drive up drug prices. America depends on ...

The Pharma stocks are seeing big cuts in early trade. The Nifty Pharma Index is down over 1% and the BSE Healthcare Index too remains under pressure. Some of the big Nifty losers include the likes ...

The Department of Justice on Monday said a lawsuit against the Food and Drug Administration seeking to sharply restrict the abortion pill mifepristone should be dismissed, continuing the position ...

The abortion pill mifepristone "is not safe and effective," argue the authors of a new study that uses insurance claim data to examine adverse reactions to the pill. They claim to have found a ...